• Technology

We are developing StromaForte, a drug candidate consisting of bone-marrow derived mesenchymal stromal cells. StromaForte is an advanced cell therapy platform, for the treatment of inflammatory and auto-immune diseases as well as for regenerative purposes. StromaForte is the result of more than 20 years research and clinical experience from Karolinska Institutet.

In addition, a new drug candidate is under development. This candidate has other properties than StromaForte and can be useful for additional medical indications.